Evrofarma SA

Athens Stock Exchange EVROF.AT

Evrofarma SA EBITDA for the year ending December 31, 2023: USD 5.86 M

Evrofarma SA EBITDA is USD 5.86 M for the year ending December 31, 2023, a 38.49% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.

Evrofarma SA EBITDA for the year ending December 31, 2022 was USD 4.23 M, a 127.61% change year over year.
Evrofarma SA EBITDA for the year ending December 31, 2021 was USD 1.86 M, a -55.56% change year over year.
Evrofarma SA EBITDA for the year ending December 31, 2020 was USD 4.19 M, a 47.87% change year over year.
Evrofarma SA EBITDA for the year ending December 31, 2019 was USD 2.83 M, a -29.20% change year over year.

Key data

Date	EBITDA	Net Income	EPS (Diluted)	Shares (Diluted, Weighted)

Athens Stock Exchange: EVROF.AT

Evrofarma SA

CEO	Mr. Paschalis H. Papazilakis
IPO Date	June 13, 2000
Location	Greece
Headquarters	1st km Didymoteicho – Orestiada
Employees	166
Sector	Consumer Staples
Industries Dairy & Milk

Description

Evrofarma SA produces and sells dairy products in Greece. It offers milk, yoghurt, cheese, and fermented beverages. The company also exports its products. Evrofarma SA was founded in 1991 and is headquartered in Didymoteicho, Greece.

Key trends

Past 5 years